Procter & Gamble (PG) Posts Q3 EPS of 92c; Trims FY15 Organic Sales Growth Outlook

(Updated - April 23, 2015 6:58 AM EDT)

Procter & Gamble (NYSE: PG) reported Q3 EPS of $0.92, versus the analyst estimate of $0.92. Revenue for the quarter came in at $18.14 billion versus the consensus estimate of $18.44 billion.

Fiscal Year 2015 Guidance

P&G said it now expects organic sales growth of low single digits for the fiscal year. Net sales growth is expected to be down five to six percent versus the prior fiscal year, including a negative six to seven percent headwind from foreign exchange and a one percent impact from minor brand divestitures.

*** P&G was previously modeling FY15 organic sales growth in the low-to-mid single digit range.

P&G maintained its outlook for currency-neutral core earnings per share growth in the double-digits. The Company also maintained guidance for Core EPS to be in-line to down low single digits versus prior year Core EPS of $4.09, consistent with analysts’ current consensus estimate. All-in GAAP diluted net earnings per share are now expected to be down approximately 21 percent to 22 percent versus the prior year. This includes approximately $0.83 per share of non-core costs, primarily from $0.20 per share of non-core restructuring charges and $0.57 of net impacts from discontinued operations.

For earnings history and earnings-related data on Procter & Gamble (PG) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• ResMed (RMD) Tops Q3 EPS by 20c
• SPS Commerce (SPSC) Tops Q1 EPS by 12c